Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
112.84
USD
-0.11 (-0.10%)
Official Closing Price
Updated: 7:59 PM EST, Jan 22, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
75
76
Next >
Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
March 18, 2020
- The test will be used on the company's m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S.
From
PR Newswire
Advancing Wearable Devices Grant Patients and Doctors Greater Flexibility
March 18, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Physicians and Patients Reap the Benefits of Innovative Medical Devices
March 13, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Absolute Enables Many Customers to Seamlessly Repair and Heal VPN Applications at No Cost as Need to Support and Secure Remote Workforces Skyrockets Amid Coronavirus Outbreak
March 10, 2020
Absolute® (ABT.TO), the leader in endpoint resilience, today announced free access for many of its existing customers to Absolute’s patented Persistence® technology in order for these customers to...
From
Business Wire News Releases
Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav™ Delivery System for the Company's Portico™ Valve
March 05, 2020
- New FlexNav™ delivery system improves control and delivery of the Portico™ TAVI valve even in complex clinical cases
From
PR Newswire
Absolute Survey at RSA Conference 2020 Reveals More than Half of Respondents Very Concerned About the Security of Endpoints
March 03, 2020
Absolute® (ABT.TO), the leader in endpoint resilience, today announced key insights from a survey of this year’s RSA Conference attendees to gauge where security and IT leaders are focusing their...
From
Business Wire News Releases
Study Demonstrates Remote CGM Initiation Successful at Improving Diabetes Outcomes and Quality of Life
February 26, 2020
Cecelia Health worked with The Jaeb Center for Health Research (JCHR) with support from The Helmsley Charitable Trust on a study that demonstrated successful remote continuous glucose monitor (CGM)...
From
PR Newswire
Technological Breakthroughs Give Rise to Wearable Patient Monitoring Devices
February 26, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Wearable Devices Open a New Frontier for Medical Tech
February 25, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Media Alert: New Report from Absolute Underscores Windows 10 as Dominant Enterprise OS, But Reveals 80 Percent of Windows 10 Devices Running on Version More than One Year Old
February 25, 2020
— RSA Conference 2020 — Absolute® (TSX:ABT), the leader in endpoint resilience, today announced early insights from the company’s upcoming 2020 State of Endpoint Resilience Report against the backdrop...
From
Business Wire News Releases
Abbott Declares 385th Consecutive Quarterly Dividend
February 21, 2020
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share.
From
PR Newswire
New Real-World Data Show that Abbott's FreeStyle Libre System Delivers Positive Health Outcomes for People with Type 1 and Type 2 Diabetes
February 20, 2020
- Data at ATTD reinforce and add to a growing body of clinical research and real-world evidence from users of the FreeStyle Libre system around the world
From
PR Newswire
Electrophysiology Market Value Projected to Exceed $5 Billion by 2022
February 19, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Electrophysiology Market Value Projected to Exceed $5 Billion By 2022
February 19, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
February 19, 2020
- Collaboration will combine Abbott's leading continuous glucose monitoring (CGM) technology with Insulet's Omnipod Horizon™ Automated Insulin Delivery System to offer an accurate, easy-to-use,...
From
PR Newswire
Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
February 18, 2020
- New Gallant™ high voltage devices offer patients and their doctors a smartphone app and Bluetooth connectivity designed to help doctors tailor therapy to a patient's unique clinical needs
From
PR Newswire
Absolute Receives Application Certification from ServiceNow
February 13, 2020
Absolute® (TSX:ABT), the leader in endpoint resilience, today announced that it has received certification of its application with ServiceNow®, available in the ServiceNow Store. Certification by...
From
Business Wire News Releases
Global Medical Device Industry Bolstering Outstanding Growth Potentials
February 11, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Medical Device Industry Bolstering Outstanding Growth Potentials
February 11, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
February 04, 2020
Abbott (NYSE: ABT) today announced that the company has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its in-development Fully Implantable Left...
From
PR Newswire
Absolute Reports Fiscal 2020 Second Quarter Financial Results
February 03, 2020
Absolute (TSX: ABT) (“Absolute” or the “Company”), the leader in endpoint resilience, today announced its financial results for the three and six months ended December 31, 2019. All dollar figures are...
From
Business Wire News Releases
Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke
February 03, 2020
- The CATALYST trial will examine Abbott's Amplatzer™ Amulet™ device compared to non-vitamin K oral anticoagulants, the current standard in attempting to lower stroke and bleeding risks for patients...
From
PR Newswire
Jean Boulle Group: European Union Approval for Tendyne Transcatheter Mitral Valve
February 03, 2020
From
ACCESSWIRE
Absolute Extends Power of Resilience to Expanded Ecosystem of Leading Endpoint Security Applications
January 31, 2020
Absolute® (ABT.TO), the leader in endpoint resilience, today announced the company is extending the power of its Resilience solution and patented Persistence® technology to a growing ecosystem of...
From
Business Wire News Releases
Medical Devices Offer a Boost to Viable and Cost-Effective Treatment Options
January 30, 2020
FinancialBuzz.com News Commentary
From
PR Newswire
Abbott's Tendyne™ Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
January 30, 2020
- First-of-its-kind technology addresses critical need to eliminate mitral regurgitation when surgery or mitral repair is not an option
From
PR Newswire
Big Changes are Coming to Healthcare Thanks to Augmented Reality
January 28, 2020
Tags
Featured News
From
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Big Changes are Coming to Healthcare Thanks to Augmented Reality
January 28, 2020
Financialnewsmedia.com News Commentary
From
PR Newswire
Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
January 24, 2020
- Abbott's Infinity™ DBS is the first FDA approved directional Deep Brain Stimulation (DBS) system to allow targeting of a specific area of the brain that is critical to motor functions
From
PR Newswire
New Quality of Life and Functional Improvement Data From Abbott's BOLD and TRIUMPH Studies Reinforce Benefit of Proclaim™ XR Neurostimulation System In People Living with Chronic Pain
January 23, 2020
- BOLD study found that BurstDR™ stimulation waveform reduced the negative psychological effects associated with a person's chronic pain at six-month follow up by 62%
From
PR Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
75
76
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.